Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 19:54:22
Organigram Glob Rg (Frankfurt)
Závěr k 13.2.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
1,13 -0,88 -0,01 5 590
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiOrganigram Global Inc
TickerOGI
Kmenové akcie:Ordinary Shares
RICOGI.TO
ISIN-
Poslední známé roční výsledky30.09.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 31.12.2025 1 137
Akcie v oběhu k 31.12.2025 135 132 782
MěnaCAD
Kontaktní informace
Ulice35A English Dr
MěstoMONCTON
PSČE1E 3X3
ZeměCanada
Kontatní osoba 
Funkce kontaktní osoby 
Telefon15 063 841 571
Fax16044847155

Business Summary: Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Financial Summary: BRIEF: For the three months ended 31 December 2025, Organigram Global Inc revenues increased 49% to C$63.5M. Net income totaled C$20M vs. loss of C$23M. Revenues reflect Gross revenue increase of 46% to C$97.3M. Net Income reflects Production & sale of medical cannabis segment loss decrease of 70% to C$3.4M. Basic Earnings per Share excluding Extraordinary Items increased from -C$0.20 to C$0.15.
Odvětvová klasifikace
TRBC2012Medical Farming
RBSS2004Precious Metals & Minerals
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICMedicinals And Botanicals



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorJames Yamanaka-15.01.202615.01.2026
Chief Financial OfficerGreg Guyatt-08.01.202408.01.2024
Chief People OfficerKatrina Mcfadden-29.08.202229.08.2022
Executive Vice President - Business DevelopmentMario Naric-06.12.202406.12.2024
Senior Vice President - OperationsNathalie Kubrick-06.10.202201.06.2021
Senior Vice President - Global Brands and Corporate AffairsMegan Mccrae-01.07.202431.05.2021
Chief Information OfficerGeoff Riggs-15.08.202215.08.2022
Chief Commercial OfficerTimothy Emberg-06.10.202202.10.2017
Chief Legal Officer, Corporate SecretaryHelen Martin-15.07.202128.11.2018